Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2012

Synta Pharmaceuticals Corp. (SNTA) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Synta Pharmaceuticals is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecule drugs to extend and improve the lives of patients suffering with severe medical conditions, including cancer and chronic inflammatory diseases. The company boasts a … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Talon Therapeutics, Inc. (TLON) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Talon Therapeutics is a biopharmaceutical company committed to identifying and seizing medical opportunities, expertly leading product candidates through clinical development and passing on value to patients, patient care providers, shareholders, corporate partners and employees. Marqibo, the company’s lead asset, as … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

pSivida Corp. (PSDV) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

pSivida Corp. is engaged in developing tiny, sustained release drug-delivery products that deliver drugs at a controlled or steady rate for months or years. The company is currently focused on the treatment of chronic diseases of the back of the … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Catalyst Pharmaceutical Partners, Inc. (CPRX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Catalyst Pharmaceutical Partners is a development-stage specialty pharmaceutical company engaged in developing and commercializing prescription drugs that target diseases and disorders of the central nervous system, including addiction and epilepsy. The company has two products in development, CPP-109 and CPP-115. … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Furiex Pharmaceuticals, Inc. (FURX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Furiex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase the value of drug development programs, cost-efficiently advancing them through the drug discovery and development process. The company’s drug development programs are designed … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Advanced Cell Technology, Inc. (ACTC) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Advanced Cell Technology is a biotechnology company focused on the application of cellular technology in the field of regenerative medicine. The company specializes in developing cellular therapies to treat diseases and conditions impacting tens of millions of people across the … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

MagneGas Corporation (MNGA) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

MagneGas Corporation is the producer of MagneGas, a natural gas alternative and metal working fuel that can be created from certain industrial, municipal, agricultural and military liquid wastes after the receipt of appropriate governmental permits. The company’s patented Plasma Arc … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

ARIAD Pharmaceuticals, Inc. (ARIA) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

ARIAD Pharmaceuticals is an emerging worldwide oncology company engaged in discovering, developing and commercializing medicines to change the lives of cancer patients. The company’s approach to structure-based drug design has resulted in several internally discovered, molecularly targeted product candidates for … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

CrowdGather, Inc. (CRWG) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

CrowdGather is one of the leading networks of forum communities on the Internet. The company’s growing portfolio of special interest forums and enthusiast message board communities has created a centralized network benefiting forum members, forum owners and forum advertisers. CrowdGather … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Dyax Corp. (DYAX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Dyax Corp. is a fully integrated biopharmaceutical company engaged in developing and commercializing novel biotherapeutics for unmet medical needs. Ecallantide, the company’s lead product, has been approved in the U.S. under the brand name KALBITOR for treating acute attacks of … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment